Patents by Inventor Michael Christiansen

Michael Christiansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230273194
    Abstract: Methods for the detection of enzymatic activity, in particular, to in vivo methods. A non-invasive method for in vivo enzyme activity detection, such as activity of proteinases, to substrates specifically developed for these methods and to a device detecting product formation of the enzyme to be tested based on determination of signals produced by the substrates and/or its products.
    Type: Application
    Filed: October 12, 2020
    Publication date: August 31, 2023
    Inventors: Simone Schürle, Michael Christiansen, Dragana Ristanovic
  • Patent number: 10491490
    Abstract: Methods, systems, and articles of manufacture to generate file transfer monitoring criteria are disclosed. An example method obtains a file transfer log file from a first network entity and obtains from the transfer log file file transfer metadata that is associated with file transfer activity between the first network entity and a second network entity. The file transfer metadata is used to generate a file transfer monitoring criterion that is associated with selectively monitoring the file transfer activity between the first network entity and the second network entity. Service level criteria associated with the file transfer event is automatically updated based on the file transfer monitoring criterion.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: November 26, 2019
    Assignee: International Business Machines Corporation
    Inventors: S Sridhar, Shamika Naik, Thurman Pylant, Michael Rieser, Steve Woodcock, Stuart D. Ander, Palanisamy Gounder, Guy Briggs, Ashish Rajput, Lalit Pant, Michael Christiansen
  • Patent number: 10323392
    Abstract: A method and apparatus for solving a prevailing problem that occurs when cooled water accumulated in hot water pipelines is wasted down the drain while an individual waits for the discharge of hot water at a point-of-use is described. The described water recovery method and apparatus prevents the waste of usable cooled water accumulated in the hot water pipelines by utilizing a diverter unit with a three-way diverter valve, a solenoid valve, and a thermoswitch to implement a cycle that diverts the accumulated cooled water to a holding container before it can be discharged at the point-of-use and allows only hot water to pass through and reach the point-of-use. As a result, the described water recovery process and apparatus allows valuable fresh water to be stored and conserved for later use.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: June 18, 2019
    Inventor: Kenneth Michael Christiansen
  • Publication number: 20180115473
    Abstract: Methods, systems, and articles of manufacture to generate file transfer monitoring criteria are disclosed. An example method obtains a file transfer log file from a first network entity and obtains from the transfer log file file transfer metadata that is associated with file transfer activity between the first network entity and a second network entity. The file transfer metadata is used to generate a file transfer monitoring criterion that is associated with selectively monitoring the file transfer activity between the first network entity and the second network entity. Service level criteria associated with the file transfer event is automatically updated based on the file transfer monitoring criterion.
    Type: Application
    Filed: December 19, 2017
    Publication date: April 26, 2018
    Inventors: S. Sridhar, Shamika Naik, Thurman Pylant, Michael Rieser, Steve Woodcock, Stuart D. Ander, Palanisamy Gounder, Guy Briggs, Ashish Rajput, Lalit Pant, Michael Christiansen
  • Publication number: 20170067235
    Abstract: A method and apparatus for solving a prevailing problem that occurs when cooled water accumulated in hot water pipelines is wasted down the drain while an individual waits for the discharge of hot water at a point-of-use is described. The described water recovery method and apparatus prevents the waste of usable cooled water accumulated in the hot water pipelines by utilizing a diverter unit with a three-way diverter valve, a solenoid valve, and a thermoswitch to implement a cycle that diverts the accumulated cooled water to a holding container before it can be discharged at the point-of-use and allows only hot water to pass through and reach the point-of-use. As a result, the described water recovery process and apparatus allows valuable fresh water to be stored and conserved for later use.
    Type: Application
    Filed: September 6, 2016
    Publication date: March 9, 2017
    Inventor: Kenneth Michael CHRISTIANSEN
  • Publication number: 20150067160
    Abstract: Methods, systems, and articles of manufacture to generate file transfer monitoring criteria are disclosed. An example method obtains a file transfer log file from a first network entity and obtains from the transfer log file file transfer metadata that is associated with file transfer activity between the first network entity and a second network entity. The file transfer metadata is used to generate a file transfer monitoring criterion that is associated with selectively monitoring the file transfer activity between the first network entity and the second network entity. Service level criteria associated with the file transfer event is automatically updated based on the file transfer monitoring criterion.
    Type: Application
    Filed: November 5, 2014
    Publication date: March 5, 2015
    Inventors: S. Sridhar, Shamika Naik, Thurman Pylant, Michael Rieser, Steve Woodcock, Dale Ander, Palanisamy Gounder, Guy Briggs, Ashish Rajput, Lalit Pant, Michael Christiansen
  • Publication number: 20120149040
    Abstract: The present invention provides a method, an assay and a kit for providing an indication of abnormal cell function. The present inventors describes ADAM12 as a overall general marker for abnormal cell function, and the present inventor for the first time demonstrate that ADAM12 is an important indicator of fetal chromosomal disease and placenta function. Specifically ADAM12 is a good marker for e.g. Downs's syndrome, trisomy 18, preeclampsia, Turner syndrome in both first and second trimester. The present inventors developed an enzyme-linked immunosorbent assay (ELISA) and a time-resolved immunofluorometric assay for the quantification of ADAM12 in serum. The present application demonstrates in several examples the variation of the ADAM12 level in fetal abnormality and/or adverse pregnancy outcomes correlated gestational age when compared to normal controls. It is an object of the invention to provide an improvement of the existing marker tests that exhibits a decreased false positive rate.
    Type: Application
    Filed: January 24, 2012
    Publication date: June 14, 2012
    Inventors: Ulla M. Wewer, Bent Norgaard-Pedersen, Michael Christiansen, Jennie Laigaard, Camilla Fröhlich, Kevin Spencer
  • Patent number: 8114609
    Abstract: The present invention provides a method, an assay and a kit for providing an indication of abnormal cell function. It was surprisingly found that the change in the serum ADAM12 concentration in individuals was useful as a prognostic tool to predict the clinical outcome, complications and mortality following an abnormal cell function. The present inventors describes ADAM12 as a overall general marker for abnormal cell function, and the present inventor for the first time demonstrate that ADAM12 is an important indicator of fetal chromosomal disease and placenta function. Specifically ADAM12 is a good marker for e.g. Downs's syndrome, trisomy 18, preeclampsia, Turner syndrome in both first and second trimester. The present inventors developed an enzyme-linked immunosorbent assay (ELISA) and a time-resolved immunofluorometric assay for the quantification of ADAM12 in serum.
    Type: Grant
    Filed: February 2, 2010
    Date of Patent: February 14, 2012
    Assignees: Statens Serum Institut, Kobenhavns Universitet, Harold Wood Hospital
    Inventors: Ulla M. Wewer, Bent Norgaard-Pedersen, Michael Christiansen, Jennie Laigaard, Camilla Frohlich
  • Publication number: 20100190174
    Abstract: The present invention provides a method, an assay and a kit for providing an indication of abnormal cell function. It was surprisingly found that the change in the serum ADAM12 concentration in individuals was useful as a prognostic tool to predict the clinical outcome, complications and mortality following an abnormal cell function. The present inventors describes ADAM12 as a overall general marker for abnormal cell function, and the present inventor for the first time demonstrate that ADAM12 is an important indicator of fetal chromosomal disease and placenta function. Specifically ADAM12 is a good marker for e.g. Downs's syndrome, trisomy 18, preeclampsia, Turner syndrome in both first and second trimester. The present inventors developed an enzyme-linked immunosorbent assay (ELISA) and a time-resolved immunofluorometric assay for the quantification of ADAM12 in serum.
    Type: Application
    Filed: February 2, 2010
    Publication date: July 29, 2010
    Inventors: Ulla M. Wewer, Bent Nørgaard-Pedersen, Michael Christiansen, Jennie Laigaard, Camilla Fröhlich
  • Patent number: 7678544
    Abstract: The present invention provides a method, an assay and a kit for providing an indication of abnormal cell function. It was surprisingly found that the change in the serum ADAM12 concentration in individuals was useful as a prognostic tool to predict the clinical outcome, complications and mortality following an abnormal cell function. The present inventors describes ADAM12 as a overall general marker for abnormal cell function, and the present inventor for the first time demonstrate that ADAM12 is an important indicator of fetal chromosomal disease and placenta function. Specifically ADAM12 is a good marker for e.g. Downs's syndrome, trisomy 18, preeclampsia, Turner syndrome in both first and second trimester. The present inventors developed an enzyme-linked immunosorbent assay (ELISA) and a time-resolved immunofluorometric assay for the quantification of ADAM12 in serum.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: March 16, 2010
    Assignees: Statens Serum Institut, Kobenhavns Universitet, Harold Wood Hospital
    Inventors: Ulla M. Wewer, Bent Nørgaard-Pedersen, Michael Christiansen, Jennie Laigaard, Camilla Fröhlich, Kevin Spencer
  • Patent number: 7478163
    Abstract: A mapping method for converting objects in order to optimize utilization of a programming environment on an associated platform includes the steps of identifying a strongly typed object and a type of conversion. A name of a weakly typed object is based upon an attribute associated with a target object and reflection is used on the strongly typed object to obtain properties of the object input parameter. Default names are assigned and stored based upon the obtained properties in a dictionary cache. The dictionary cache is used to complete attributes associated with new object for use in the programming environment.
    Type: Grant
    Filed: February 4, 2004
    Date of Patent: January 13, 2009
    Inventors: Anthony Arthur J. Alda, Brent Richard Bysouth, Ricardo J. Rosado, Zubin Adi Balsara, Carla Maureen Ulrich, Lloyd Clayton Dwayne Bell, Ryan Michael Christiansen, Andrew Viewkko Poystila, David Brett Rudd, Shazron Abdullah
  • Publication number: 20060294474
    Abstract: Systems and methods are disclosed for providing a user interface. The disclosed systems and methods may include receiving a request to initiate an application program configured to generate a data file. Furthermore, the disclosed systems and methods may include displaying, by the initiated application program, a property panel in response to the request. The property panel may be configured to receive meta-data to be associated with the data file generated by the application program. Also, the property panel may be configured to provide the only place to receive the meta-data by the application program. Moreover, the disclosed systems and methods may include receiving the meta-data in the property panel.
    Type: Application
    Filed: June 24, 2005
    Publication date: December 28, 2006
    Applicant: Microsoft Corporation
    Inventors: Brandon Taylor, Brian Jones, Hani Saliba, Jeffrey Johnson, Lauren Antonoff, Michael Christiansen, Raj Merchant, Steven Sinofsky
  • Publication number: 20060248165
    Abstract: Methods, systems, and articles of manufacture to generate file transfer monitoring criteria are disclosed. An example method obtains a file transfer log file from a first network entity and obtains from the transfer log file file transfer metadata that is associated with file transfer activity between the first network entity and a second network entity. The file transfer metadata is used to generate a file transfer monitoring criterion that is associated with selectively monitoring the file transfer activity between the first network entity and the second network entity. Service level criteria associated with the file transfer event is automatically updated based on the file transfer monitoring criterion.
    Type: Application
    Filed: April 27, 2005
    Publication date: November 2, 2006
    Inventors: S. Sridhar, Shamika Naik, Thurman Pylant, Michael Rieser, Steve Woodcock, Stuart Ander, Palanisamy Gounder, Guy Briggs, Ashish Rajput, Lalit Pant, Michael Christiansen
  • Publication number: 20060134654
    Abstract: The present invention provides a method, an assay and a kit for providing an indication of abnormal cell function. It was surprisingly found that the change in the serum ADAM12 concentration in individuals was useful as a prognostic tool to predict the clinical outcome, complications and mortality following an abnormal cell function. The present inventors describes ADAM12 as a overall general marker for abnormal cell function, and the present inventor for the first time demonstrate that ADAM12 is an important indicator of fetal chromosomal disease and placenta function. Specifically ADAM12 is a good marker for e.g. Downs's syndrome, trisomy 18, preeclampsia, Turner syndrome in both first and second trimester. The present inventors developed an enzyme-linked immunosorbent assay (ELISA) and a time-resolved immunofluorometric assay for the quantification of ADAM12 in serum.
    Type: Application
    Filed: May 18, 2005
    Publication date: June 22, 2006
    Inventors: Ulla Wewer, Bent Norgaard-Pedersen, Michael Christiansen, Jennie Laigaard, Camilla Frohlich, Kevin Spencer
  • Patent number: 6490450
    Abstract: A system and method for capturing and modifying roaming mobile subscriber information such as Serving MSCID, cell and sector location information, original dialed digits, subscriber profile and return address point code in support of service applications, such as wireless prepaid service for roaming subscribers. A network platform is inserted into the signaling path between a roaming subscriber's HLR and all Serving MSCs. The network platform intercepts messages exchanged between the roaming subscriber's Serving MSC and HLR, and extracts and stores information such as Serving MSCID, cell and sector data. The network platform may also modify the exchanged messages in support of service applications.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: December 3, 2002
    Assignee: AG Communication Systems Corporation
    Inventors: Ramachendra Prahlada Batni, Axel Michael Christiansen, Baijun Zhao
  • Patent number: 6467489
    Abstract: A finger nail cap having a casing of plastics material having a transparent upper side, a lower side shaped to fit onto a wearer's nail, and a cavity with a chemilunminescent chemical therebetween, and frangible means holding a catalyst in isolation in the cavity or a valve through one of the sides to allow for introduction of a catalyst to the chemical.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: October 22, 2002
    Assignee: Nova Glo International Ltd.
    Inventor: Gregory John Michael Christiansen
  • Patent number: 5898917
    Abstract: Enhanced services are accessed from an enhanced services network element of a cellular radio telecommunications system using a cellular carrier specific code (#CCSC) string based office-level trigger and IS-41 messaging protocol message types. The invention takes advantage of the #CCSC standard to define MSC office-based trigger criteria wherein the dialed digits must start with the "#" character. When a call is received by the MSC in which the digits dialed start with "#" followed by a digit sequence, and an office-based trigger is provisioned for the "#" sequence dialed, the MSC suspends call processing and a service query message is generated and sent to the SCP of the requested enhanced service. The SCP then sends a response message back to the MSC, which resumes call processing in accordance with the response from the SCP.
    Type: Grant
    Filed: August 27, 1996
    Date of Patent: April 27, 1999
    Assignee: AG Communication Systems Corporation
    Inventors: Ramachendra Prahlada Batni, Axel Michael Christiansen
  • Patent number: 5833951
    Abstract: Finely disperse, emulsifier-free cosmetic or dermatological formulations of the oil-in-water type, comprisingan oily phase comprising, as the main constituent, one or more non-polar oils, fats and/or waxes,an aqueous phase,one or more thickeners selected from the group consisting of acrylic polymers, polysaccharides and alkyl ethers thereof, these thickeners not being allowed to have emulsifier properties,and, if desired, comprising customary cosmetic or dermatological auxiliaries, additives and/or active compounds.
    Type: Grant
    Filed: May 19, 1997
    Date of Patent: November 10, 1998
    Assignee: Beiersdorf AG
    Inventors: Dorte Artz, Michael Christiansen, Uwe Schonrock, Sigrid Steinke
  • Patent number: 5804167
    Abstract: Finely disperse, emulsifier-free cosmetic or dermatological formulations of the water-in-oil type, comprisingoily phase comprising, as the main constituent, or more non-polar oils, fats and/or waxes,aqueous phase, or more salts of di- and/or trivalent metal cations and one or more alkylcarboxylic acids having 10-24 C atoms,and, if desired, comprising customary cosmetic or dermatological auxiliaries, additives and/or active compounds.
    Type: Grant
    Filed: October 2, 1996
    Date of Patent: September 8, 1998
    Assignee: Beiersdorf AG
    Inventors: Uwe Schonrock, Michael Christiansen, Sigrid Steinke